Top Gainers for 1-24-23: $BIAF $BXRX $CANF $GROM $INPX

$BIAF - bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research: https://finance.yahoo.com/news/bioaffinity-technologies-announces-publication-results-130000525.html

$BXRX - Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000: https://finance.yahoo.com/news/baudax-bio-announces-positive-outcome-130000794.html

$CANF - Can-Fite: Namodenoson Significantly Inhibits Pancreatic Cancer in Preclinical Studies—A Patent Has Been Filed: https://finance.yahoo.com/news/fite-namodenoson-significantly-inhibits-pancreatic-120000207.html

$GROM - GROM: A Promising Children’s Entertainment Company with Big Plans, Run By Industry Veterans (1/23/2023): https://finance.yahoo.com/news/grom-promising-children-entertainment-company-104600156.html

$INPX - Inpixon Secures Purchase Order Valued at Over $1 Million for its RTLS Products from a Leading Transportation and Industrial Equipment Provider (1/20/2022): https://finance.yahoo.com/news/inpixon-secures-purchase-order-valued-143000184.html